KR20130101529A - Ttll4 펩티드 및 이를 포함하는 백신 - Google Patents

Ttll4 펩티드 및 이를 포함하는 백신 Download PDF

Info

Publication number
KR20130101529A
KR20130101529A KR1020137008815A KR20137008815A KR20130101529A KR 20130101529 A KR20130101529 A KR 20130101529A KR 1020137008815 A KR1020137008815 A KR 1020137008815A KR 20137008815 A KR20137008815 A KR 20137008815A KR 20130101529 A KR20130101529 A KR 20130101529A
Authority
KR
South Korea
Prior art keywords
peptide
ttll4
ser
seq
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020137008815A
Other languages
English (en)
Korean (ko)
Inventor
유스케 나카무라
타쿠야 츠노다
류지 오사와
Original Assignee
온코세라피 사이언스 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 온코세라피 사이언스 가부시키가이샤 filed Critical 온코세라피 사이언스 가부시키가이샤
Publication of KR20130101529A publication Critical patent/KR20130101529A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/10Cellular immunotherapy characterised by the cell type used
    • A61K40/11T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/40Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41Vertebrate antigens
    • A61K40/42Cancer antigens
    • A61K40/4202Receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020137008815A 2010-09-07 2011-09-06 Ttll4 펩티드 및 이를 포함하는 백신 Withdrawn KR20130101529A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38061110P 2010-09-07 2010-09-07
US61/380,611 2010-09-07
PCT/JP2011/004987 WO2012032764A1 (en) 2010-09-07 2011-09-06 Ttll4 peptides and vaccines containing the same

Publications (1)

Publication Number Publication Date
KR20130101529A true KR20130101529A (ko) 2013-09-13

Family

ID=45810374

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137008815A Withdrawn KR20130101529A (ko) 2010-09-07 2011-09-06 Ttll4 펩티드 및 이를 포함하는 백신

Country Status (13)

Country Link
US (1) US20130224234A1 (enExample)
EP (1) EP2614146A4 (enExample)
JP (1) JP2013540419A (enExample)
KR (1) KR20130101529A (enExample)
CN (1) CN103189510B (enExample)
AU (1) AU2011300253B2 (enExample)
BR (1) BR112013005448A2 (enExample)
CA (1) CA2810636A1 (enExample)
MX (1) MX2013002303A (enExample)
RU (1) RU2013115434A (enExample)
SG (1) SG187847A1 (enExample)
TW (1) TW201210608A (enExample)
WO (1) WO2012032764A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2015123315A (ru) * 2012-11-25 2017-01-10 Зе Реджентс Оф Зе Юниверсити Оф Калифорния Пептиды, стимулирующие подкожный адипогенез
WO2015184125A1 (en) 2014-05-28 2015-12-03 The Regents Of The University Of California Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
CN111041028B (zh) * 2019-12-20 2024-05-17 陕西省人民医院 人ttll4基因的用途及相关产品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
AU2003254950A1 (en) * 2002-08-26 2004-03-11 Kirin Beer Kabushiki Kaisha Peptides and drugs containing the same
WO2004092207A2 (en) * 2003-04-16 2004-10-28 Algonomics N.V. Respiratory syncytial virus (rsv) peptides
EP2334790A1 (en) * 2008-08-27 2011-06-22 Oncotherapy Science, Inc. Pancreatic cancer related gene ttll4

Also Published As

Publication number Publication date
WO2012032764A1 (en) 2012-03-15
EP2614146A1 (en) 2013-07-17
AU2011300253A1 (en) 2013-03-21
AU2011300253B2 (en) 2015-01-15
CN103189510B (zh) 2015-05-06
SG187847A1 (en) 2013-03-28
CN103189510A (zh) 2013-07-03
RU2013115434A (ru) 2014-10-20
EP2614146A4 (en) 2014-02-12
JP2013540419A (ja) 2013-11-07
MX2013002303A (es) 2013-10-28
CA2810636A1 (en) 2012-03-15
BR112013005448A2 (pt) 2019-09-24
TW201210608A (en) 2012-03-16
US20130224234A1 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
KR102213574B1 (ko) Kntc2 펩티드 및 이를 포함하는 백신
KR102020491B1 (ko) Topk 펩티드 및 이를 포함하는 백신
KR101841475B1 (ko) 변형된 melk 펩티드 및 이를 함유하는 백신
KR102110873B1 (ko) Ube2t 펩티드 및 이를 포함하는 백신
WO2011125334A1 (en) Cdca5 peptides and vaccines including the same
KR102015648B1 (ko) Mphosph1 펩티드 및 이를 포함한 백신
KR20140026543A (ko) Sema5b 펩티드 및 이를 포함한 백신
KR102004900B1 (ko) Tomm34 펩티드 및 이를 포함한 백신
KR20120029394A (ko) Ttk 펩티드 및 이를 포함한 백신
KR101872284B1 (ko) Hjurp 펩티드 및 이를 포함한 백신
WO2012032764A1 (en) Ttll4 peptides and vaccines containing the same
WO2011074236A1 (en) Tmem22 peptides and vaccines including the same
WO2011067933A1 (en) Mybl2 peptides and vaccines containing the same
KR20130033367A (ko) Ect2펩티드 및 이를 포함한 백신
CN103282494B (zh) C18orf54肽及包含它们的疫苗
KR20130138804A (ko) Wdhd1 펩티드 및 이를 포함한 백신
KR20130043632A (ko) Cluap1 펩티드 및 이를 포함한 백신

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130405

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid